EU BIOTECH CAMPUS
0776.668.706 · rovalta.com · 25/09/2026
EU BIOTECH CAMPUS
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBOEU BIOTECH CAMPUS is a Non-profit organization incorporated in 2021. Its main activity is: Activities of other membership organisations n.e.c.. Its registered office is in Charleroi.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0776.668.706
- Incorporation
- 29/10/2021
- Legal form
- Non-profit organization
- Registered office
- Rue Clément Ader 10
6041 Charleroi · WallonieSee on map - Latest accounts
- 31/12/2024
Joint committees (1)
- 32902
Financials
Source · NBB, 3 filingsTrend over 3 financial years
| 2024 | 2023 | 2022 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Gross margin | 89,7 k € | +128% | -319 k € | -1003% | 35,3 k € |
| EBITDA | -185,8 k € | +41.9% | -319,7 k € | -1016% | 34,9 k € |
| Operating result | -191,3 k € | +40.6% | -322 k € | -1022% | 34,9 k € |
| Net result | -175,2 k € | +40.1% | -292,4 k € | -946% | 34,5 k € |
| Balance sheet | |||||
| Equity | 4 M € | -8.5% | 4,4 M € | -6.2% | 4,7 M € |
| Total assets | 8,6 M € | +87.2% | 4,6 M € | -13.8% | 5,3 M € |
| Cash | 210,5 k € | -91.6% | 2,5 M € | -44.0% | 4,5 M € |
| Debts | 4,5 M € | +2567% | 170 k € | -72.2% | 612,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20246 active · 4 ended
Active mandates
Other companies at this address
Rue Clément Ader 10 6041 Charleroi| Company | CBE no. |
|---|---|
2 Bridge WL● Active | 1003.906.745 |
3D Fibroscreen● Active | 1022.772.354 |
AdipoPharma Belgique● Active | 1008.146.338 |
ATRYON BELGIUM● Active | 0751.698.530 |
| 0479.250.670 | |
ConvEyXo● Active | 0725.874.259 |
CONVEYXO GROUP● Active | 1016.957.797 |
ELKEDONIA BELGIUM● Active | 1021.635.177 |
ENDO TOOLS THERAPEUTICS● Active | 0807.570.233 |
Enodia Therapeutics Belgium● Active | 1039.324.811 |
Exo-Harvest● Active | 0803.425.264 |
Hemastatx● Active | 1019.406.058 |
Immunofusion● Active | 0804.563.629 |
ImmunXperts● Active | 0552.755.587 |
INCHINN THERAPEUTICS● Active | 0799.914.755 |
INSTAR BELGIQUE● Active | 1039.395.085 |
KOKUMA● Active | 0799.078.377 |
LYS MEDICAL● Active | 0688.626.061 |
MILEUTIS● Active | 1011.400.984 |
Nexelis Europe● Active | 0744.498.061 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 21/10/2021 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 |
| Length of the financial year | 12 months | 12 months | 15 months |
| Filing date | 18/09/2025 | 02/08/2024 | 26/06/2023 |
| General meeting | 17/07/2025 | 05/07/2024 | 15/06/2023 |
| Currency of the financial year | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 3 filingsValuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20246 active · 4 ended
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-175,2 k €↑
- 2023Annual accounts 2023-292,4 k €↓
- 2022Annual accounts 202234,5 k €
- 29/10/2021IncorporationNon-profit organization